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Abstract The protein mediating system L amino acid transport,
AmAT-L, is a disulfide-linked heterodimer of a permease-related
light chain (AmAT-L-lc) and the type II glycoprotein 4F2hc/
CD98. The Schistosoma mansoni protein SPRM1 also hetero-
dimerizes with h4F2hc, inducing amino acid transport with
different specificity. In this study, we show that the disulfide bond
is formed by heavy chain C109 with a Cys residue located in the
second putative extracellular loop of the multi-transmembrane
domain light chain (C164 and C137 for XAmAT-L-lc and
SPRM1, respectively). The non-covalent interaction of Cys-
mutant subunits is not sufficient to allow coimmunoprecipitation,
but cell surface expression of the light chains is maintained to a
large extent. The non-covalently linked transporters display the
same transport characteristics as disulfide bound heterodimers,
but the maximal transport rates are reduced by 30^80%.
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1. Introduction
The glycoprotein h4F2hc (CD98 in mouse) induces low lev-
els of amino acid transport of L- and yL-type when ex-
pressed alone in Xenopus laevis oocytes and/or some other
cells [1^4]. Because of its likely topology with only one single
transmembrane domain (type II membrane glycoprotein), it
was suggested that h4F2hc acts as an activator or modulator
of amino acid transport [1,2], possibly by binding to endoge-
nous ‘light chains’. Indeed, from older studies, this surface
antigen is known to migrate at the level of V80 kDa on
SDS-PAGE and to be covalently associated with a hydropho-
bic light chain which appears as a 40-kDa band on SDS-
PAGE [5,6].
We recently described the permease-related human protein
E16 (hAmAT-L-lc) as the ¢rst light chain of h4F2hc [7]. We
showed that indeed hAmAT-L-lc and its Xenopus laevis ho-
mologue XAmAT-L-lc (ASUR4) induce high levels of L-type
amino acid transport (Na-independent exchange of large
neutral amino acids) when coexpressed with h4F2hc in Xeno-
pus oocytes, but not when expressed alone. Similar transport
properties were reported for the rat homologue TA1 [8]. We
showed that XAmAT-L-lc and h4F2hc form a heterodimer
(AmAT-L) that migrates as a band of approximately
120 kDa on SDS-PAGE in non-reducing conditions and
that, in the presence of a reducing agent, additional bands
of 80 kDa and 40 kDa appear, indicating that heavy and light
chains are linked by a disul¢de bond [7]. SPRM1, a Schisto-
soma mansoni membrane protein with 40% identity to XA-
mAT-L-lc was also shown to heterodimerize with h4F2hc.
This led to its surface expression and to the induction of
amino acid transport with a di¡erent speci¢city, i.e. Na-in-
dependent transport of cationic amino acids and partially
Na-dependent transport of large neutral amino acids [7].
In the present study we show by site directed mutagenesis
that C109 of the heavy chain h4F2hc and C164 and C137 of
the light chains XAmAT-L-lc and SPRM1, respectively, form
the disul¢de bond linking the heterodimer subunits covalently
together and that the absence of disul¢de bond does not pre-
clude, but only decreases transporter surface expression and/
or function.
2. Materials and methods
2.1. Point mutations
For introduction of the point mutation C109S in the h4F2hc cDNA
the primer 5P-AGCGCCGCGTTCTCGCGAGCTACC-3P (sense) and
the corresponding antisense primer containing the mutation were gen-
erated (mutated bases are underlined). These primers were used to
amplify the plasmid containing the template cDNA of h4F2hc by
PCR using Pfu DNA polymerase (Stratagene) according the manu-
facturers protocol. Following temperature cycling, template DNA was
selectively digested with the DNA methylation-dependent restriction
enzyme DpnI. The same method was used to introduce the point
mutations C164S in XAmAT-L-lc and C137S in SPRM1 using the
primers 5P-TTCCCTACCTCCCCCGTGCCCGAT-3P and 5P-CGTC-
TACATGGACAGTGTTACTCCTAC-3P (sense).
2.2. Xenopus laevis oocytes
Oocytes were treated with collagenase A for 2^3 h at room temper-
ature in Ca2-free bu¡er containing: 82.5 mM NaCl, 2 mM KCl,
1 mM MgCl2, 10 mM HEPES/Tris, pH 7.4, to remove follicular cells
and then kept at 16‡C in ND96 bu¡er containing: 96 mM NaCl,
2 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2, 5 mM HEPES/Tris, pH
7.4.
2.3. Amino acid uptake
Oocytes were injected with 5 ng of each cRNA dissolved in 33 nl
water. Oocytes were then kept for 24 h at 16‡C in ND96 bu¡er.
Before experiments, oocytes were washed 6 times in uptake bu¡er
containing: 100 mM choline-Cl, 2 mM KCl, 1 mM MgCl2, 1 mM
CaCl2, 10 mM HEPES/Tris, pH 7.4. Six oocytes per uptake condition
were preincubated at 22‡C for 2 min. Then, the bu¡er was exchanged
for 100 Wl uptake bu¡er supplemented with amino acid at the indi-
cated concentration and tritiated amino acid as tracer. Uptakes were
performed for 1 min because initial experiments showed linear uptake
during this time. Oocytes were then washed 5 times with 3 ml bu¡er,
distributed to individual vials and lysed in 2% SDS. Radioactivity was
counted by liquid scintillation.
2.4. Labeling of oocytes and immunoprecipitation
After cRNA injection (as for uptake experiments), oocytes were
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incubated for 48 h in ND96 bu¡er supplemented with 1 mCi/ml
[35S]methionine. Oocytes were then washed twice in ND96 bu¡er
and lysed in 20 Wl/oocyte oocyte lysis bu¡er containing: 120 mM
NaCl, 50 mM Tris-HCl, pH 8.0, 0.5% NP40 supplemented with pro-
tease inhibitors. Lysates were vortexed for 20 s and incubated shortly
on ice and centrifuged for 10 min at 12 000 rpm at 4‡C. Incorporated
radioactivity was determined by TCA-precipitation.
Antibodies for h4F2hc (monoclonal antibody [6] and SPRM1 (af-
¢nity puri¢ed rabbit anti-peptide antibody) were provided by L. Kuºhn
and P. Skelly, respectively. Antibody for XAmAT-L-lc was raised
against a peptide corresponding to amino acids 30^45 coupled to
keyhole limpet hemocyanin (Eurogentec, Seraing, Belgium) and a⁄n-
ity puri¢ed. Aliquots of lysate containing equal amounts of counts
were precleared twice for 30 min at 4‡C with protein G plus/protein A
agarose beads (Calbiochem). Antibodies were bound to protein G
plus/protein A agarose for 2 h at room temperature in oocyte lysis
bu¡er and added to the precleared lysate. After overnight incubation
at 4‡C beads were washed 6 times in bu¡er containing: 100 mM
NaCl, 20 mM Tris-HCl, pH 8.0, 1 mM EDTA, 500 mM LiCl, 0.5%
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Fig. 1. Membrane topology model of a heterodimeric amino-acid
transporter of the AmAT family. hc indicates the single transmem-
brane domain of the heavy chain h4F2hc. Putative transmembrane
domains of the lipophilic light chain are numbered 1^12. The Cys
residues 109 in h4F2hc and 164 in XAmAT-L-lc (corresponds to
C137 in SPRM1) are linked by a disul¢de bond. Two other Cys res-
idues which are present in XAmAT-L-lc and SPRM1 as well as
C330 of h4F2hc which is also present in CD98 are indicated. Poten-
tial N-glycosylation sites are indicated by forks.
6
Fig. 2. Immunoprecipitation of wild type and Cys-mutant h4F2hc and light chains XAmAT-L-lc and SPRM1 expressed in oocytes with anti-
h4F2hc (A), anti-SPRM1 (B1^10) and anti-XAmAT-L-lc antibody (B10^15), followed by SDS-PAGE and £uorography. A: XAmAT-L-lc or
SPRM1 coprecipitated with h4F2hc appears as additional band of 40 kDa in reducing conditions and remains associated with h4F2hc in non-
reducing conditions migrating as heterodimer of V120 kDa. In C109Sh4F2hc and C164SXAmAT-L-lc or C137SSPRM1 expressing oocytes the light
chain is not coprecipitated. B: Wild-type h4F2hc is coprecipitated with wild-type XAmAT-L-lc and SPRM1 light chain. No coprecipitation of
the heavy chain is seen with C109Sh4F2hc and C146SXAmAT-L-lc or C137SSPRM1. wt: wild type; m: Cys to Ser mutants (see Section 2); X.l.lc:
XAmAT-L-lc; S.m.lc. : SPRM1; Lme: L-mercaptoethanol.
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NP40 and 6 times in bu¡er containing: 100 mM NaCl, 20 mM Tris-
HCl, pH 8.0, 1 mM EDTA, 0.5% NP40. Beads were resuspended in
SDS-PAGE sample bu¡er and heated to 65‡C for 15 min. L-Mercap-
toethanol was added where indicated and SDS-PAGE analysis
was performed. Gels were stained in Coomassie blue and ¢xed. After
incubation in Amplify (Amersham), gels were dried and exposed to
¢lm.
2.5. Immunocytochemistry
Oocytes were ¢xed with 3% paraformaldehyde in PBS for 4 h at
4‡C, 24 h after injection of the cRNAs. Anti-h4F2hc antibody (2 Wg/
ml) followed by a 1:1000 dilution of a Cy-3 conjugated goat anti-
mouse Ig (Jackson Immuno Research Laboratories, West Grove, PA,
USA) and anti-SPRM1 antibody diluted 1:4000 and followed by a
1:100 dilution of a horseradish peroxidase (HRP)-conjugated donkey-
anti-rabbit Ig (Jackson) were used on cryosections (6 Wm thick) of the
¢xed oocytes. The HRP-conjugated secondary antibody was revealed
with FITC-tyramide conjugates (TSA-Direct, NEN, Boston, MA,
USA) which were diluted 1:75 in the TSA ampli¢cation diluent. Sec-
tions were studied by epi£uorescence and digitized images were ac-
quired with a VISICAM CCD camera (Visitron, Puchheim, Germany)
and processed by Image-Pro Plus v3.0 software (Media Cybernetics,
Silver Spring, MD, USA) (same settings for all images with same
antibody).
3. Results
For the di¡erent light chains belonging to the AmAT-lc
family, hydropathy analysis as well as analysis with the
TMpred program (ISREC) predict a 12 transmembrane do-
main topology with the N- and C-termini in the cytosol. Ac-
cording to this prediction, the only extracellular Cys residue
which is conserved in AmAT-L-lc’s, SPRM1 and the light
chains which induce system yL-type amino acid transport
(AmAT-yL-lc’s) (Pfei¡er et al., manuscript submitted) is lo-
cated in the second extracellular loop and corresponds to
C164 in XAmAT-L-lc and C137 in SPRM1, respectively.
This suggested the involvement of these Cys residues in the
disul¢de bond linking the light chain to the heavy chain and
prompted us to test this possibility by mutating them to Ser
and testing the resulting mutant light chains in Xenopus oo-
cytes.
The heavy chain of the heterodimers, the type II glycopro-
tein h4F2hc, has a large extracellular domain containing only
2 Cys residues, one of which is close to the transmembrane
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Fig. 3. Amino acid uptake in Xenopus oocytes expressing wild-type h4F2hc and XAmAT-L-lc or SPRM1 and Cys mutants (wt: wild type;
164S: C164SXAmAT-L-lc; 137S: C137SSPRM1). A: L-Leucine (1 mM) uptake was similar in non-injected oocytes and oocytes expressing h4F2hc,
C109Sh4F2hc, XAmAT-L-lc or C164SXAmAT-L-lc only. The increase in L-leucine uptake observed in oocytes coexpressing h4F2hc and XAmAT-
L-lc was reduced in oocytes coexpressing C109Sh4F2hc. Coexpression of C109Sh4F2hc and C164SXAmAT-L-lc results in a further reduction of up-
take. L-Leucine uptake was inhibited by an excess of BCH (10 mM) (A2), but not by MeAIB (10 mM) (A3). B: L-Arginine (1 mM) uptake by
oocytes expressing C109Sh4F2hc, SPRM1 or C137SSPRM1 only was slightly less than that by h4F2hc expressing oocytes. The increase in L-argi-
nine transport observed in oocytes coexpressing h4F2hc and SPRM1 is diminished in oocytes coexpressing C109Sh4F2hc and SPRM1 and further
reduced in oocytes coexpressing C109Sh4F2hc and C137SSPRM1. L-Arginine transport by the heterodimer of h4F2hc and SPRM1 is not inhibited
by BCH (10 mM) (B2) and MeAIB (10 mM) (B3). Means of 18 oocytes þ S.E.M. pooled from 3 independent experiments are shown.
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domain. This is also the only one to be conserved between
h4F2hc and the related glycoprotein rBAT, a glycoprotein
expressed at the apical surface of small intestine and kidney
proximal tubule which induces b0;-like amino acid transport
when it is expressed in Xenopus oocytes. This, as well as re-
sults obtained with h4F2hc-transferrin receptor chimeras
(Rothenberger and Kuºhn, personal communication) and
with h4F2hc expressed alone in Xenopus oocytes (EsteveŁs et
al., in press) prompted us to test by site directed mutation
whether this Cys109 residue indeed is forming the disul¢de
bridge with the light chain. The model shown in Fig. 1 cor-
responds to the heterodimer formed by h4F2hc and the Xeno-
pus light chain XAmAT-L-lc or the Schistosoma mansoni
chain SPRM1 as proposed above and subsequently con¢rmed
by the experimental work described below.
3.1. Coimmunoprecipitation of heavy and light chains depends
on the Cys residues indicated in the model
To test the hypothesis that the Cys residues C164 in XA-
mAT-L-lc or C137 in SPRM1 and C109 in h4F2hc are form-
ing disul¢de bridges in heterodimers, we performed coimmu-
noprecipitations using wild type and the mutated chains
described above expressed in Xenopus oocytes. Fig. 2A shows
the SDS-PAGE analysis of immunopreciptiations made with
the anti-h4F2hc antibody. The expected band of 80 kDa ap-
peared in oocytes expressing h4F2hc only (lanes 1, 2, 11, 12),
and, in contrast, no protein was precipitated when oocytes
were injected with either of the light chains alone (lanes 3,
7, 13, 17) [7]. In non-reducing conditions, coinjection of
h4F2hc/XAmAT-L-lc or h4F2hc/SPRM1 resulted, as previ-
ously shown, in the appearance of a band at V120 kDa,
which corresponds to a heterodimer (lanes 14, 18). As ex-
pected, the heterodimer could be separated by the addition
of the reducing agent L-mercaptoethanol as shown by the
additional band at 40 kDa corresponding to the coprecipi-
tated light chain (lanes 4, 8). No coprecipitation was seen
with C109Sh4F2hc coexpressed with a wild-type light chain
nor with wild-type h4F2hc coexpressed with a mutant light
chain (lanes 5, 6, 9, 10, 15, 16, 19, 20). These results con¢rm
that C109 of h4F2hc, and C164 and C137 in XAmAT-L-lc
and SPRM1, respectively, form a disul¢de bond in the heter-
odimer. The lack of coprecipitation of Cys-mutants is com-
patible with the possibility that the formation of the interac-
tion between heavy and light chain or its stability during cell
lysis and/or immunoprecipitation depends on the covalent
bond.
Immunoprecipitations were also performed using anti-
SPRM1 antibody (Fig. 2B) which con¢rmed the results ob-
tained with anti-h4F2hc antibody. The expected band at a
molecular weight of 40 kDa was seen with lysate of oocytes
injected with SPRM1 alone (lanes 3, 9). In h4F2hc/SPRM1
coinjected oocytes, h4F2hc was coprecipitated and migrated
as a 80-kDa band (lane 4) or aV120-kDa band (heterodimer,
lane 10) in reducing or non-reducing conditions, respectively.
Again there was no coprecipitation of C109Sh4F2hc coinjected
with SPRM1 or wild-type h4F2hc coinjected with
C137SSPRM1 (lanes 5, 6, 11, 12). Anti-XAmAT-L-lc antibody
also precipitated XAmAT-L-lc (lane 15) and C164SXAmAT-L-
lc and coprecipitation of h4F2hc was only seen when wild-
type XAmAT-L-lc and h4F2hc where coexpressed (lane 16).
The fact that three di¡erent antibodies directed against
epitopes were situated on di¡erent sites (heavy chain extra-
cellular domain, light chain N-terminal or C-terminal region)
supports the idea that the absence of coprecipitation in our
experimental conditions is due to the intrinsic instability of
the subunit interaction and not a destabilizing e¡ect of the
antibody.
3.2. Amino acid transport is only reduced in the absence of
covalent binding between subunits
To test the role of the disul¢de bond in the function of
AmAT, wild-type heavy and light chains and mutated heavy
and/or light chains were expressed in Xenopus oocytes (Fig.
3A,B). L-Leucine uptakes in XAmAT-L-lc (Fig. 3A1) and
L-arginine uptakes in SPRM1 (Fig. 3B1) expressing oocytes,
respectively, were performed in the absence of Na. After
24 h expression, the background uptake of L-leucine and
L-arginine by oocytes injected with C109Sh4F2h, h4F2hc,
C164SXAmAT-L-lc, C137SSPRM1 or the wild-type light chains
alone was similar to that of non-injected oocytes. Coexpres-
sion of wild-type heavy and light chain induced a substantial
increase in amino acid uptake, as expected [7]. However, when
C109Sh4F2hc was coexpressed with wild-type XAmAT-L-lc or
SPRM1, the induced transport was reduced to V30^70% of
that obtained with wild-type h4F2hc. The transport was even
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Fig. 4. Dose dependence of amino acid uptake in Xenopus oocytes
coexpressing h4F2hc and XAmAT-L-lc or SPRM1 and Cys mu-
tants. A: L-Leucine uptake by oocytes coexpressing h4F2hc/XA-
mAT-L-lc (b), C109Sh4F2hc/XAmAT-L-lc (a), h4F2hc/C164SXAmAT-
L-lc (F) and C109Sh4F2hc/C164SXAmAT-L-lc (E). B: L-Arginine up-
take by oocytes coexpressing h4F2hc/SPRM1 (b), C109Sh4F2hc/
SPRM1 (a), h4F2hc/C137SSPRM1 (F) and C109Sh4F2hc/C137SSPRM1
(E). Uptakes were performed at 4 di¡erent amino acid concentra-
tions, background uptake by oocytes expressing h4F2hc or
C109Sh4F2hc was subtracted and curves corresponding to Michaelis-
Menten kinetics were ¢tted to the experimental data using non-line-
ar regression analysis. Means of 12 oocytes þ S.E.M. pooled from
2 independent experiments are shown.
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slightly lower (V20^50% of wild type), when a mutated light
chain was coexpressed with wild-type h4F2hc. Transport rate
of oocytes coinjected with mutated heavy and light chains was
similar to that of oocytes coinjected with wild-type h4F2hc
and mutated light chain.
Qualitatively, the transport characteristics of the non-cova-
lently bound heterodimeric transporter were not discernible
from those of wild-type transporter. For instance, L-leucine
transport by XAmAT-L-lc/h4F2hc is blocked to the same ex-
tent in all combinations of mutants by the competitive inhib-
itor 2-amino-2-norbornane-carboxylic acid (BCH) (Fig. 3A2).
As expected, methyl-aminoisobutyrate (MeAIB), the speci¢c
inhibitor of system A amino acid transport had no e¡ect (Fig.
3A3). Amino acid transport mediated by the heterodimer of
SPRM1 and h4F2hc has been shown to be di¡erent from that
mediated by the heterodimer of XAmAT-L-lc and h4F2hc and
di¡ers from all described mammalian amino acid transport
systems. As expected BCH (Fig. 3B2) and MeAIB (Fig.
3B3) had no inhibitory e¡ect on SPRM1.
To investigate further the potential e¡ect of the mutations
on transport kinetics, uptakes of L-leucine in the case of XA-
mAT-L-lc (Fig. 4A) and L-arginine (Fig. 4B) in the case of
SPRM1 were performed at 4 di¡erent amino acid concentra-
tions in the absence of Na. Oocytes were injected with
h4F2hc or C109Sh4F2hc alone or the indicated combinations
of heavy and light chains. Background uptake by oocytes
injected with h4F2hc or C109Sh4F2hc alone was subtracted
from uptake by coinjected oocytes and sigmoidal curves
were ¢tted to the experimental data such that amino acid
concentrations for half-maximal activation (apparent Km)
could be derived. No major reproducible di¡erence in appa-
rent Km was observed in oocytes coinjected with h4F2hc and
any of the mutated light chains, C109Sh4F2hc and wild-type
light chains or C109Sh4F2hc and mutated light chains (appa-
rent Km 10^54 WM for L-leucine uptakes by h4F2hc/XAmAT-
L-lc combinations and 16^73 WM for L-arginine uptake by
h4F2hc/SPRM1 combinations). However, Vmax was reduced
to a similar extent as seen in Fig. 3.
3.3. Surface expression is not prevented by lack of disul¢de
bridge between subunits
We have previously shown by immuno£uorescence that
h4F2hc expressed alone was localized at the surface of oocytes
and that, in contrast, the AmAT transporter light chain was
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Fig. 5. Double immuno£uorescence of h4F2hc and the light chain SPRM1 in oocyte sections. Injected cRNAs are indicated at the left side of
each panel pair (same section) while the detecting antibody is indicated on the top of each panel. h4F2hc and SPRM1 colocalize at the cell sur-
face, whether or not they are linked by a disul¢de bond, in contrast to SPRM1 expressed alone which is not localized at the surface [7]. Bar:
20 Wm.
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localized intracellularly when expressed alone, and required
coexpression of h4F2hc to localize at the surface [7]. To test
whether h4F2hc is able to promote the surface expression of a
non-covalently bound AmAT-light chain, double immuno-
£uorescence experiments were performed using antibodies to
h4F2hc and SPRM1. As shown in Fig. 5, coexpression of
mutant chains (C137SSPRM1 and C109Sh4F2hc), which cannot
form a disul¢de bridge with their heterodimer partner, never-
theless leads to a substantial cell surface localization and no
intracellular accumulation of the light chain. This result sug-
gests that heterodimer interaction takes place also in the ab-
sence of disul¢de bridge formation between the subunits and
that this interaction is stable enough to allow cell surface
expression of the light chain, in the context of the oocyte
system.
4. Discussion
AmAT-L, composed of h4F2hc and hAmAT-L-lc or XA-
mAT-L-lc is the ¢rst heterodimeric transporter for organic
substrates of vertebrates known as yet [7]. Characteristics of
transport depend on the light chain associated with the 4F2
heavy chain. The function(s) of the heavy chain are not yet
entirely elucidated. It has been shown in oocytes that the light
chain was localized mainly intracellularly when injected alone,
however, it was localized to a large extent at the plasma mem-
brane when coexpressed with h4F2hc [7]. This led to the hy-
pothesis that the heavy chain h4F2hc is important for matu-
ration, tra⁄cking and/or surface residence of the light chain.
Interestingly, h4F2hc has an overall structure (glycosylated
type II membrane protein) which resembles that of the L-sub-
unit of Na,K-ATPase. This plasma membrane enzyme has a
minimal functional unit composed of an K-L heterodimer
which is, though, not covalently linked. Similarly to the
AmAT amino acid transporters, it also performs a transmem-
brane exchange of substrates, i.e. three intracellular Na for
two extracellular K. For the Na,K-ATPase, it has been
shown that the type II glycoprotein L-subunit is needed for
stabilization, functional maturation and transport, from the
endoplasmic reticulum to the plasma membrane, of the cata-
lytic multi-transmembrane domain K-subunit [9]. We hypothe-
size that the 4F2 heavy chain type II glycoprotein ful¢lls a
similar function towards its permease-related AmAT light
chains.
Heavy and light chain are linked by a disul¢de bridge which
is shown in this study to be not essential for the surface ex-
pression and the function of the transporters. Nevertheless,
the disul¢de linked Cys-residues in the light chain are con-
served in amphibia and mammals and even the £at worm
Schistosoma mansoni. This indicates that covalent linkage of
the heterodimer must be of importance. Our experiments
show that the non-covalent interaction of heavy and light
chain is not very strong, since coimmunoprecipitation was
not observed after cell lysis and immunoprecipitation in
non-denaturing conditions. In vivo, a missing disul¢de bond
might decrease the ability of the heavy chain to heterodimer-
ize, and/or reduce the stability of interaction and thus de-
crease the amount of light chain brought to the membrane.
A reduced stability of interaction might also decrease the time
of residence of functional units at the cell surface.
Interestingly, the Cys residue in the heavy chain is also
conserved in rBAT, another glycoprotein heavy chain which
induces amino acid transport of type b0;-like characteristics
[10,11]. Possibly (a) light chain(s) of the same AmAT-lc family
heterodimerize with rBAT. Interestingly, expression experi-
ments with rBAT truncated at its C terminus [12] have sug-
gested that this other putative ‘heavy chain’ might modulate
the transport characteristics of its light chain or, alternatively,
that the mutation in£uenced the a⁄nity for di¡erent putative
endogenous light chains of the oocyte. As 4F2hc and rBAT
are localized at the basolateral and apical membrane of epi-
thelial cells, respectively [13,14], they might determine the ba-
solateral or apical surface localization of their respective light
chains.
In conclusion, we have identi¢ed the Cys residues forming
the disul¢de bond between heavy and light chain of hetero-
dimeric amino acid transporter of the AmAT family. We have
shown that transport characteristics and apparent Km remain
unchanged in the non-covalently bound transporter whereas
maximal transport activity is reduced. These ¢ndings are com-
patible with the hypothesis that the heavy chain is important
for maturation, tra⁄cking and/or surface residence of the cat-
alytic light chain.
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